Citigroup’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.8K | Sell |
13,335
-15,500
| -54% | -$59.1K | ﹤0.01% | 4019 |
|
|
2025
Q1 | $75.8K | Sell |
28,835
-3,678
| -11% | -$9.67K | ﹤0.01% | 3972 |
|
|
2024
Q4 | $115K | Buy |
32,513
+4,096
| +14% | +$14.5K | ﹤0.01% | 3920 |
|
|
2024
Q3 | $130K | Buy |
28,417
+22,240
| +360% | +$101K | ﹤0.01% | 3864 |
|
|
2024
Q2 | $26.9K | Buy |
6,177
+1,404
| +29% | +$6.11K | ﹤0.01% | 4171 |
|
|
2024
Q1 | $24K | Buy |
4,773
+622
| +15% | +$3.12K | ﹤0.01% | 4227 |
|
|
2023
Q4 | $26K | Buy |
4,151
+4,130
| +19,667% | +$25.9K | ﹤0.01% | 4131 |
|
|
2023
Q3 | $150 | Sell |
21
-10,103
| -100% | -$72.2K | ﹤0.01% | 4588 |
|
|
2023
Q2 | $103K | Buy |
10,124
+9,860
| +3,735% | +$100K | ﹤0.01% | 3568 |
|
|
2023
Q1 | $2.39K | Buy |
264
+4
| +2% | +$36 | ﹤0.01% | 4357 |
|
|
2022
Q4 | $1.86K | Buy |
+260
| New | +$1.86K | ﹤0.01% | 4490 |
|
|
2021
Q2 | – | Sell |
-465
| Closed | -$3K | – | 5611 |
|
|
2021
Q1 | $3K | Sell |
465
-741
| -61% | -$4.78K | ﹤0.01% | 5340 |
|
|
2020
Q4 | $6K | Buy |
1,206
+870
| +259% | +$4.33K | ﹤0.01% | 4984 |
|
|
2020
Q3 | $3K | Sell |
336
-368
| -52% | -$3.29K | ﹤0.01% | 4854 |
|
|
2020
Q2 | $5K | Sell |
704
-249
| -26% | -$1.77K | ﹤0.01% | 4828 |
|
|
2020
Q1 | $7K | Buy |
+953
| New | +$7K | ﹤0.01% | 4737 |
|
|
2019
Q4 | – | Sell |
-767
| Closed | -$5K | – | 5178 |
|
|
2019
Q3 | $5K | Sell |
767
-258
| -25% | -$1.68K | ﹤0.01% | 4798 |
|
|
2019
Q2 | $3K | Sell |
1,025
-654
| -39% | -$1.91K | ﹤0.01% | 4963 |
|
|
2019
Q1 | $5K | Sell |
1,679
-149
| -8% | -$444 | ﹤0.01% | 4890 |
|
|
2018
Q4 | $7K | Sell |
1,828
-1,189
| -39% | -$4.55K | ﹤0.01% | 4708 |
|
|
2018
Q3 | $18K | Buy |
3,017
+514
| +21% | +$3.07K | ﹤0.01% | 4547 |
|
|
2018
Q2 | $14K | Sell |
2,503
-36,284
| -94% | -$203K | ﹤0.01% | 4518 |
|
|
2018
Q1 | $481K | Buy |
+38,787
| New | +$481K | ﹤0.01% | 2334 |
|